Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. Angelis, A., Lange, A., & Kanavos, P. The European Journal of Health Economics, 19(1):123–152, January, 2018. Paper doi abstract bibtex Background Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.
@article{angelis_using_2018-1,
title = {Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight {European} countries},
volume = {19},
issn = {1618-7598, 1618-7601},
shorttitle = {Using health technology assessment to assess the value of new medicines},
url = {http://link.springer.com/10.1007/s10198-017-0871-0},
doi = {10.1007/s10198-017-0871-0},
abstract = {Background Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.},
language = {en},
number = {1},
urldate = {2019-05-02},
journal = {The European Journal of Health Economics},
author = {Angelis, Aris and Lange, Ansgar and Kanavos, Panos},
month = jan,
year = {2018},
pages = {123--152},
file = {Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:/Users/neil.hawkins/Zotero/storage/KYVDPC2D/Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:application/pdf},
}
Downloads: 0
{"_id":"FWJEgvF2qNumChMP6","bibbaseid":"angelis-lange-kanavos-usinghealthtechnologyassessmenttoassessthevalueofnewmedicinesresultsofasystematicreviewandexpertconsultationacrosseighteuropeancountries-2018","author_short":["Angelis, A.","Lange, A.","Kanavos, P."],"bibdata":{"bibtype":"article","type":"article","title":"Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries","volume":"19","issn":"1618-7598, 1618-7601","shorttitle":"Using health technology assessment to assess the value of new medicines","url":"http://link.springer.com/10.1007/s10198-017-0871-0","doi":"10.1007/s10198-017-0871-0","abstract":"Background Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.","language":"en","number":"1","urldate":"2019-05-02","journal":"The European Journal of Health Economics","author":[{"propositions":[],"lastnames":["Angelis"],"firstnames":["Aris"],"suffixes":[]},{"propositions":[],"lastnames":["Lange"],"firstnames":["Ansgar"],"suffixes":[]},{"propositions":[],"lastnames":["Kanavos"],"firstnames":["Panos"],"suffixes":[]}],"month":"January","year":"2018","pages":"123–152","file":"Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:/Users/neil.hawkins/Zotero/storage/KYVDPC2D/Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:application/pdf","bibtex":"@article{angelis_using_2018-1,\n\ttitle = {Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight {European} countries},\n\tvolume = {19},\n\tissn = {1618-7598, 1618-7601},\n\tshorttitle = {Using health technology assessment to assess the value of new medicines},\n\turl = {http://link.springer.com/10.1007/s10198-017-0871-0},\n\tdoi = {10.1007/s10198-017-0871-0},\n\tabstract = {Background Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2019-05-02},\n\tjournal = {The European Journal of Health Economics},\n\tauthor = {Angelis, Aris and Lange, Ansgar and Kanavos, Panos},\n\tmonth = jan,\n\tyear = {2018},\n\tpages = {123--152},\n\tfile = {Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:/Users/neil.hawkins/Zotero/storage/KYVDPC2D/Angelis et al. - 2018 - Using health technology assessment to assess the v.pdf:application/pdf},\n}\n\n","author_short":["Angelis, A.","Lange, A.","Kanavos, P."],"bibbaseid":"angelis-lange-kanavos-usinghealthtechnologyassessmenttoassessthevalueofnewmedicinesresultsofasystematicreviewandexpertconsultationacrosseighteuropeancountries-2018","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/s10198-017-0871-0"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["using","health","technology","assessment","assess","value","new","medicines","results","systematic","review","expert","consultation","eight","european","countries","angelis","lange","kanavos"],"title":"Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries","year":2018}